Histoplasma Galactomannan Antigen by EIA, Quantitative, Other Body Fluids
Also known as: HISTO GAL
Use
Aids in the diagnosis of histoplasmosis. It is recommended to perform this test in conjunction with Histoplasma Antibodies by Complement Fixation and Immunodiffusion and Histoplasma Galactomannan Antigen Quantitative by EIA, Urine for comprehensive evaluation. The measurement of histoplasma galactomannan antigen levels helps to identify active infection by Histoplasma capsulatum, a causal agent of histoplasmosis.
Special Instructions
Not provided.
Limitations
This test may cross-react with antigens from Blastomyces spp., Coccidioides spp., and Paracoccidioides brasiliensis. It has not been cleared or approved by the FDA, though FDA clearance is not required for its clinical use. Results are not intended as the sole means for clinical diagnosis or patient management and should be interpreted in the context of clinical findings.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
Histoplasma Galactomannan Antigen
Analyte
Result Turnaround Time
3-4 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
2 mL
Minimum Volume
1.2 mL
Container
ARUP standard transport tube
Collection Instructions
Transfer specified volume to ARUP standard transport tube.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 2 weeks |
| Refrigerated | 2 weeks |
| Frozen | Indefinitely |
Other tests from different labs that may be relevant